(marketscreener.com) FLINT, Mich., Aug. 9, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO) today announced that its Board of Directors is reviewing strategic alternatives. At the direction of its Board of Directors, the company is reviewing strategic alternatives focused on maximizing shareholder value. The...http://www.marketscreener.com/DIPLOMAT-PHARMACY-INC-18164874/news/Diplomat-Pharmacy-Announces-Review-of-Strategic-Alternatives-29040450/?utm_medium=RSS&utm_content=20190809